ANN ARBOR, Mich., Oct. 12, 2021 /PRNewswire/ -- Patients diagnosed with a rare cancer called Epithelioid Sarcoma face many challenges that will impact their outcome, beginning with the lengthy ...
Epithelioid sarcoma, a rare aggressive cancer that usually strikes young adults, and rhabdoid tumors, which affect children, have long been difficult to treat. But the outlook for people with these ...
Leila Janah, a fierce entrepreneur who worked to help those living below the poverty line, died in January from complications of epithelioid sarcoma -- a form of cancer. Leila Janah, a fierce ...
Epithelioid sarcoma is a rare and aggressive soft-tissue tumour that poses significant diagnostic and therapeutic challenges. Characterised principally by the loss of SMARCB1/INI1 expression, the ...
The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. The investigators note that with US Food and Drug Administration approval of the ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (Nasdaq:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing novel epigenetic therapies, today announced that the U.S. Food ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved sirolimus protein-bound particles for injectable suspension (albumin-bound) for treatment of ...
JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results